retatrutide phase 2 results 2024 2025

retatrutide phase 2 results 2024 2025 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide UK Guide: Key Facts

Name: retatrutide phase 2 results 2024 2025 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide UK Guide: Key Facts
Brand: www.himachallive.in
SKU: 15762656022
Price: 22.19 USD
Availability: InStock
Rating: 4.4293000000000005 (8 reviews)

SKU: 15762656022

4.4

EUR22.19 EUR61.19

Pay in 4 interest-free payments of $5.55 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Description

IGF-1R Binding and Downstream Signalling IGF-1 LR3 remains a full agonist of the IGF-1 receptor, with very low affinity for IGFBPs making it more potent than unmodified IGF-1 in cell culture and pre-clinical models